We welcome you to share our blog content. We want to connect people with the information they need. We just ask that you link back to the original post and refrain from editing the text. Any questions? Email Barbara Gabriel.
By Blair Burnett, Senior Policy Analyst, <em>ACCC</em>
Summer in Washington, D.C., has always had a strong correlation to heated political activity. As the temperatures climb this month, proposed policies to reform the way the Centers for Medicare & Medicaid Services (CMS) pays providers for drugs and services are heating up as well. On July 12, 2018, CMS released its CY 2019 proposed Physician Fee Schedule rule, putting forward some significant proposals to reduce reimbursement for new Medicare Part B drugs, which could negatively impact patient access to newer anti-cancer therapies, and to streamline payment for E&M codes, which will hurt specialty care. Some good news from the rule includes two new payment codes for physician services delivered using telemedicine and proposed changes for year three of the Quality Payment Program.
While ACCC staff continue to analyze the proposed PFS rule, below are top-line takeaways that we think will be most important for ACCC members and their patients:
ACCC will host a webinar for members on the proposed CY 2019 PFS and OPPS rules in August – stay tuned for more information. ACCC will be submitting comments to the proposed rules and encourages our members to do the same.
Public comments are due on Monday, September 10.
ACCC members are encouraged to contact the ACCC policy team with any questions or concerns.